Compare MEDP & SF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MEDP | SF |
|---|---|---|
| Founded | 1992 | 1890 |
| Country | United States | United States |
| Employees | N/A | 9000 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 11.4B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | SF |
|---|---|---|
| Price | $422.73 | $76.18 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 7 |
| Target Price | ★ $473.17 | $90.33 |
| AVG Volume (30 Days) | 449.8K | ★ 1.1M |
| Earning Date | 04-22-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | ★ 20.98 | N/A |
| EPS | ★ 4.28 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.19 | $14.58 |
| Revenue Next Year | $7.75 | $8.03 |
| P/E Ratio | $100.52 | ★ $20.53 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $284.48 | $69.31 |
| 52 Week High | $628.92 | $134.74 |
| Indicator | MEDP | SF |
|---|---|---|
| Relative Strength Index (RSI) | 39.63 | 43.05 |
| Support Level | $382.68 | $75.78 |
| Resistance Level | $477.04 | $83.82 |
| Average True Range (ATR) | 16.56 | 2.40 |
| MACD | -2.21 | -0.01 |
| Stochastic Oscillator | 31.48 | 8.80 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Stifel Financial is a diversified financial-services provider that generates revenue from wealth management, investment banking, and lending. The firm was founded in 1890 as a St. Louis-based full-service brokerage but has been transformed under CEO Ronald Kruszewski through a slew of acquisitions into a globally competitive wealth manager, investment bank, and retail and institutional brokerage. The firm generated $5.5 billion in revenue in 2025, with roughly two-thirds derived from wealth management and one-third derived from investment banking and trading.